← Leaderboards
John Franklin Kearney
University Of Alabama At Birmingham
$21,145,276
Attributed
$21,145,276
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.3M · FY2005–23$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$26,182,697 · 12
By mechanism
R01$14,348,433 · 5
P01$6,794,846 · 2
U19$2,233,293 · 1
U01$1,856,250 · 1
R21$583,625 · 2
R56$366,250 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Jan Novak$14,197,925
Others in their field
Top investigators on “Antibodies”
- Lawrence Corey · Fred Hutchinson Cancer Center$525,765,536
- Bambra Strokes · Ppd Development Lp$461,655,950
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$385,009,925
- Barton F Haynes · Duke University$372,611,596
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$323,573,074
- Dennis R. Burton · Scripps Research Institute$306,733,901
Research focus
AntibodiesBaseOrganismImmuneB-LymphocytesInfectionMediatingAntigensCellsResponseB Cell RepertoireBacteriaAntibody FormationNovel TherapeuticsMouse ModelPreventImmune ResponseLifeSpecificityT-LymphocyteB-Cell DevelopmentVaccinationAdultEpitopes
Grant awards (68)
Development and maintenance of human glycan and phospholipid antibody repertoires$718,871
U19 · FY2023 · AI · contact PI
Development and maintenance of human glycan and phospholipid antibody repertoires$444,525
U19 · FY2022 · AI · contact PI
Development and maintenance of human glycan and phospholipid antibody repertoires$375,672
U19 · FY2021 · AI · contact PI
Effects of neonatal microbial exposure on anti-polysaccharide B cell development$371,250
U01 · FY2021 · AI · contact PI
Effects of neonatal microbial exposure on anti-polysaccharide B cell development$371,250
U01 · FY2020 · AI · contact PI
Regulation of B cell Clonal Diversity and Its Role in Disease$367,500
R01 · FY2020 · AI · contact PI
Development and maintenance of human glycan and phospholipid antibody repertoires$355,718
U19 · FY2020 · AI · contact PI
Effects of neonatal microbial exposure on anti-polysaccharide B cell development$371,250
U01 · FY2019 · AI · contact PI
Regulation of B cell Clonal Diversity and Its Role in Disease$367,500
R01 · FY2019 · AI · contact PI
Development and maintenance of human glycan and phospholipid antibody repertoires$338,507
U19 · FY2019 · AI · contact PI
Effects of neonatal microbial exposure on anti-polysaccharide B cell development$371,250
U01 · FY2018 · AI · contact PI
Regulation of B cell Clonal Diversity and Its Role in Disease$367,500
R01 · FY2018 · AI · contact PI
Effects of neonatal microbial exposure on anti-polysaccharide B cell development$371,250
U01 · FY2017 · AI · contact PI
Regulation of B cell Clonal Diversity and Its Role in Disease$367,500
R01 · FY2017 · AI · contact PI
Antibody induction by Group B streptococcal vaccines for protection against fungal infections$183,750
R21 · FY2017 · AI · contact PI
Regulation of B cell Clonal Diversity and Its Role in Disease$367,500
R01 · FY2016 · AI · contact PI
Effects of neonatal microbial exposure on anti-polysaccharide B cell development$361,325
R01 · FY2016 · AI · contact PI
Antibody induction by Group B streptococcal vaccines for protection against fungal infections$220,500
R21 · FY2016 · AI · contact PI
Effects of neonatal microbial exposure on anti-polysaccharide B cell development$456,875
R01 · FY2015 · AI · contact PI
Regulation of B cell Clonal Diversity and Its Role in Disease$366,250
R01 · FY2015 · AI · contact PI
Effects of neonatal microbial exposure on anti-polysaccharide B cell development$75,705
R01 · FY2015 · AI · contact PI
Regulation of B cell Clonal Diversity and Its Role in Disease$366,250
R01 · FY2014 · AI · contact PI
Effects of neonatal microbial exposure on anti-polysaccharide B cell development$309,875
R01 · FY2014 · AI · contact PI
Regulation of B cell Clonal Diversity and Its Role in Disease$344,275
R01 · FY2013 · AI · contact PI
Effects of neonatal microbial exposure on anti-polysaccharide B cell development$303,678
R01 · FY2013 · AI · contact PI
Regulation of B cell Clonal Diversity and Its Role in Disease$366,250
R01 · FY2012 · AI · contact PI
Immunobiology of Bacillus anthracis Spore-Host Interactions$362,588
R01 · FY2012 · AI · contact PI
Effects of neonatal microbial exposure on anti-polysaccharide B cell development$309,875
R01 · FY2012 · AI · contact PI
Regulation of B cell Clonal Diversity and Its Role in Disease$366,250
R01 · FY2011 · AI · contact PI
Immunobiology of Bacillus anthracis Spore-Host Interactions$362,588
R01 · FY2011 · AI · contact PI
Immunobiology of Bacillus anthracis Spore-Host Interactions$366,250
R01 · FY2010 · AI · contact PI
The Influence of Anti-N-Acetyl-D-Glucosamine B cells on Type One Diabetes in Mice$366,250
R56 · FY2010 · AI · contact PI
Regulation of B Cell Clonal Diversity$343,026
R01 · FY2010 · AI · contact PI
Immunobiology of Bacillus anthracis Spore-Host Interactions$366,042
R01 · FY2009 · AI · contact PI
Regulation of B Cell Clonal Diversity$346,491
R01 · FY2009 · AI · contact PI
Immunity to Bacillus anthracis: Spore-Host Interactions$1,014,513
P01 · FY2008 · AI · contact PI
Bacillus Anthracis Spore -Host Interactions$352,255
P01 · FY2008 · AI · contact PI
Regulation of B Cell Clonal Diversity$346,491
R01 · FY2008 · AI · contact PI
Terminal Transferase and Lymphocyte Development$337,184
R01 · FY2008 · AI · contact PI
Immunity to Bacillus anthracis: Spore-Host Interactions$999,723
P01 · FY2007 · AI · contact PI
Regulation of B Cell Clonal Diversity$353,201
R01 · FY2007 · AI · contact PI
Bacillus Anthracis Spore -Host Interactions$347,118
P01 · FY2007 · AI · contact PI
Terminal Transferase and Lymphocyte Development$343,715
R01 · FY2007 · AI · contact PI
Isoforms of Human Terminal Transferase and Lymphopoiesis$206,229
R01 · FY2007 · AI · contact PI
Immunity to Bacillus anthracis: Spore-Host Interactions$999,589
P01 · FY2006 · AI · contact PI
Regulation of B Cell Clonal Diversity$363,750
R01 · FY2006 · AI · contact PI
Bacillus Anthracis Spore -Host Interactions$355,427
P01 · FY2006 · AI · contact PI
Terminal Transferase and Lymphocyte Development$353,981
R01 · FY2006 · AI · contact PI
Isoforms of Human Terminal Transferase and Lymphopoiesis$212,389
R01 · FY2006 · AI · contact PI
Immunity to Bacillus anthracis: Spore-Host Interactions$1,005,469
P01 · FY2005 · AI
Terminal Transferase and Lymphocyte Development$362,500
R01 · FY2005 · AI
REGULATION OF B CELL CLONAL DIVERSITY$358,750
R01 · FY2005 · AI
Bacillus Anthracis Spore -Host Interactions$349,115
P01 · FY2005 · AI
Isoforms of Human Terminal Transferase and Lymphopoiesis$217,500
R01 · FY2005 · AI
Immunity to Bacillus anthracis: Spore-Host Interactions$1,018,127
P01 · FY2004 · AI
Terminal Transferase and Lymphocyte Development$362,500
R01 · FY2004 · AI
REGULATION OF B CELL CLONAL DIVERSITY$358,750
R01 · FY2004 · AI
Bacillus Anthracis Spore -Host Interactions$353,510
P01 · FY2004 · AI
Isoforms of Human Terminal Transferase and Lymphopoiesis$217,500
R01 · FY2004 · AI
REGULATION OF B CELL CLONAL DIVERSITY$358,750
R01 · FY2003 · AI
TERMINAL TRANSFERASE AND B CELL DEVELOPMENT$284,840
R01 · FY2003 · AI
Isoforms of Human Terminal Transferase and Lymphopoiesis$217,500
R01 · FY2003 · AI
REGULATION OF B CELL CLONAL DIVERSITY$358,750
R01 · FY2002 · AI
TERMINAL TRANSFERASE AND B CELL DEVELOPMENT$278,400
R01 · FY2002 · AI
REGULATION OF B CELL CLONAL DIVERSITY$306,433
R01 · FY2001 · AI
TERMINAL TRANSFERASE AND B CELL DEVELOPMENT$272,148
R01 · FY2001 · AI
TERMINAL TRANSFERASE AND B CELL DEVELOPMENT$266,079
R01 · FY2000 · AI
REGULATION OF B CELL CLONAL DIVERSITY$179,375
R21 · FY2000 · AI